Cardiac effects of Ledipasvir plus sofosbuvir for Hepatitis C treatment in thalassemia: .
作者信息
Karimi-Sari H, Khosravi A, Behnava B, Abedi-Andani M, Alavian S M
机构信息
Student Research Committee, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Baqiyatallah Research Center for Gastroenterology and Liver Diseases (BRCGL), Baqiyatallah University of Medical Sciences, Tehran, Iran.
出版信息
Porto Biomed J. 2017 Sep-Oct;2(5):191-192. doi: 10.1016/j.pbj.2017.07.039. Epub 2017 Sep 1.
Abstract
摘要
相似文献
1
Cardiac effects of Ledipasvir plus sofosbuvir for Hepatitis C treatment in thalassemia: .
Porto Biomed J. 2017 Sep-Oct;2(5):191-192. doi: 10.1016/j.pbj.2017.07.039. Epub 2017 Sep 1.
2
Acute changes in cardiac function by direct acting antiviral therapy for hepatitis C-infected patients with thalassemia.
J Med Virol. 2019 Mar;91(3):419-427. doi: 10.1002/jmv.25314. Epub 2018 Oct 9.
3
Ledipasvir + sofosbuvir (Harvoni). A therapeutic advance in genotype 1 hepatitis C virus infection, despite uncertainties.
Prescrire Int. 2015 Dec;24(166):285-9.
4
Three patients treated with sofosbuvir plus ledipasvir for recurrent hepatitis C after liver transplantation.
Clin J Gastroenterol. 2017 Apr;10(2):179-184. doi: 10.1007/s12328-017-0722-7. Epub 2017 Feb 21.
5
Retreatment efficacy and predictors of ledipasvir plus sofosbuvir to HCV genotype 1 in Japan.
J Med Virol. 2017 Feb;89(2):284-290. doi: 10.1002/jmv.24617. Epub 2016 Jul 6.
6
Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS).
Lancet Infect Dis. 2015 Apr;15(4):397-404. doi: 10.1016/S1473-3099(15)70050-2. Epub 2015 Mar 13.
7
Ledipasvir/sofosbuvir fixed-dose combination tablet in Taiwanese patients with chronic genotype 1 hepatitis C virus.
J Gastroenterol Hepatol. 2016 Jul;31(7):1323-9. doi: 10.1111/jgh.13305.
8
Ledipasvir-sofosbuvir and sofosbuvir plus ribavirin in patients with chronic hepatitis C and bleeding disorders.
Haemophilia. 2017 Mar;23(2):198-206. doi: 10.1111/hae.13178. Epub 2017 Jan 25.
9
Generic ledipasvir-sofosbuvir for patients with chronic hepatitis C: A real-life observational study.
J Hepatol. 2017 Jun;66(6):1123-1129. doi: 10.1016/j.jhep.2017.01.025. Epub 2017 Feb 9.
10
Ledipasvir/sofosbuvir with or without ribavirin for 8 or 12 weeks for the treatment of HCV genotype 4 infection: results from a randomised phase III study in Egypt.
Gut. 2019 Apr;68(4):721-728. doi: 10.1136/gutjnl-2017-315906. Epub 2018 Apr 17.
本文引用的文献
1
High incidence of cardiac dysfunction and response to antiviral treatment in patients with chronic hepatitis C virus infection.
Clin Res Cardiol. 2017 Jul;106(7):551-556. doi: 10.1007/s00392-017-1086-1. Epub 2017 Feb 24.
2
Outcome of Combination Therapy with Sofosbuvir and Ledipasvir for Chronic Type C Liver Disease.
Oncology. 2017;92 Suppl 1:3-9. doi: 10.1159/000451010. Epub 2016 Dec 15.
3
Trend in Prevalence of Hepatitis C Virus Infection among β-thalassemia Major Patients: 10 Years of Experience in Iran.
Int J Prev Med. 2015 Sep 8;6:89. doi: 10.4103/2008-7802.164832. eCollection 2015.
Zotero 插件